Product Pipline Avirmax Biopharma Inc. is at clinical stage of biotherapeutics development using rAAV delivery system. Currently, it is developing multiple rAAV candidates. The following are examples of Avirmax Biopharma’s product pipelines under development. Indication Lead Design & Production AAV - Vector Biochemical Potency Preclinical IND - Enabling Phase 1 Commercial Rights Wet AMD incl. PCV ABI-110 0% GA / dry AMD ABI-201 0% PDR ABI-202 0% Glaucoma ABI-902 0% AMD: Age-related macular degenerationGA: geographic atrophyPCV: Polypoidal choroidal vasculopathyES: EndostatinPDR: Proliferative diabetic retinopathy